PGR and breast cancer: Although the viability of human mammary epithelial cell line MCF10A tends to decrease when treated with increasing doses of HCT and PR extracts (Figure 3), IC20 and IC50 of both extracts in normal cells MCF10A were higher than in breast cancer cells MCF-7 and MDA-MB-231 (Table 5).